Sign in
4

Changes in Ownership

Fulcrum Therapeutics, Inc. Filed Acc 0000899243-22-024528

Options or other derivatives

  • Director acquired 19,000 shares (grant or award)
  • Director disposed of 500 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Ezekowitz Alan Director 2022-06-27 Grant or award · Stock Option (right to buy) +19,000 19,000 D
Ezekowitz Alan Director 2022-06-28 Other disposition · Stock Option (right to buy) −500 14,500 D
Loading xslF345X03/doc4.xml…